WallStreetZenWallStreetZen

NASDAQ: NVCR
Novocure Ltd Stock Ownership - Who owns Novocure?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novocure Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mukund ParavasthuChief Operating Officer2025-11-042,949$12.23
$36.07kSell
Christoph BrackmannChief Financial Officer2025-11-047,033$12.23
$86.01kSell
Frank X. LeonardEVP Pres. Novocure Oncology2025-11-01966$12.81
$12.37kSell
Mukund ParavasthuChief Operating Officer2025-11-01168$12.81
$2.15kSell
Michal Nath PuriChief Human Resources Officer2025-10-31752$12.82
$9.64kSell
Ashley CordovaChief Executive Officer2025-09-0581,550$12.22
$996.87kBuy
Christoph BrackmannChief Financial Officer2025-07-295,000$11.60
$58.00kBuy
Christoph BrackmannChief Financial Officer2025-07-295,000$11.50
$57.50kBuy
Christoph BrackmannChief Financial Officer2025-07-2910,000$11.63
$116.30kBuy
Michal Nath PuriChief Human Resources Officer2025-06-30833$15.13
$12.60kBuy

1 of 9

NVCR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCR insiders and whales buy or sell their stock.

NVCR Shareholders

What type of owners hold Novocure Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
William F. Doyle22.71%25,430,468$325.76MInsider
Fmr LLC14.98%16,769,878$214.82MInstitution
Gert L. Perlhagen12.52%14,018,365$179.58MInsider
Blackrock Inc12.46%13,947,558$178.67MInstitution
Vanguard Group Inc9.34%10,455,841$133.94MInstitution
Hansjoerg Wyss8.73%9,780,397$125.29MInsider
Soleus Capital Management LP8.61%9,644,872$123.55MInstitution
Volati Ltd6.44%7,216,789$92.45MInsider
Pomona Capital VII LP2.45%2,741,925$35.12MInsider
State Street Corp2.33%2,610,688$33.44MInstitution

1 of 3

NVCR vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCR58.30%41.70%Net BuyingNet Buying
BBNX91.82%8.18%Net BuyingNet Selling
AXGN59.86%40.14%Net SellingNet Selling
AHCO50.16%49.84%Net Selling
CNMD97.24%2.76%Net SellingNet Selling
View Top Medical Device Stocks

Novocure Stock Ownership FAQ

Who owns Novocure?

Novocure (NASDAQ: NVCR) is owned by 81.93% institutional shareholders, 58.61% Novocure insiders, and 0.00% retail investors. William F. Doyle is the largest individual Novocure shareholder, owning 25.43M shares representing 22.71% of the company. William F. Doyle's Novocure shares are currently valued at $297.03M.

If you're new to stock investing, here's how to buy Novocure stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.